Clinical trial
Stroke in Young Fabry Patients (sifap1): Frequency of Fabry Disease in an Unselected Group of Young Stroke Patients: an International, Multicentre Prevalence Study
NCT00414583 is registered in ClinicalTrials.gov with CENTOGENE GmbH Rostock as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Stroke in Young Fabry Patients (sifap1): Frequency of Fabry Disease in an Unselected Group of Young Stroke Patients: an International, Multicentre Prevalence Study
- Lead sponsor
- CENTOGENE GmbH Rostock
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2008
- Completion date
- January 31, 2010
- Enrollment
- 5,000 (actual)
- Sites
- 45
Conditions
As the registry lists them; a condition with its own page is linked.
cerebrovascular accident